Clinical Trial

A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2026 (before its estimated August 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine the pharmacokinetic and safety of BMS-986435 in participants with normal hepatic function and participants with different degrees of hepatic impairment
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-18.
Status change: Not Yet Recruiting → Recruiting 2026-06-10
Trial Details
NCT Number NCT07248839
Lead Sponsor Bristol-Myers Squibb
Conditions Healthy Volunteers, Hepatic Impairment
Enrollment 24 participants
Start Date 2025-12-15
Primary Completion 2026-08-05 (estimated)
Study Completion 2026-08-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-12